International Journal of Ocular Oncology and Oculoplasty (IJOOO) an open access, peer-reviewed quarterly journal publishing since 2015 and being published under auspices of the “Khyati Education and Research Foundation (KERF)”. The aim of faster and better dissemination of knowledge, we will be publishing article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in IJOOO.
Manuscripts must be prepared in accordance with “Uniform requirements for Manuscripts submitted to Biomedical Journals” as per guidelines by the International Committee of Medical Journals Editors (Updated December 2019). The uniform requirements and specific requirement of IJOOO is mentioned as below. Before sending a manuscript contributors are requested to check for the author guidelines are available from the website of journal (https://www.ipinnovative.com/journals/IJOOO) or directly from (Innovative Pre-Publication Portal) manuscript submission website https://innovpub.org/
Scope of the Journal
The aim and commitment of the journal is to publish research-oriented manuscript address significant issue in all the subjects and areas of Ocular Oncology and Oculoplasty. Journal is committed itself to improve Education and Research on Blurred Vision, Cataract, Macular Degeneration, Glaucoma, Diabetic Retinopathy, Refractive Error, Internal Medicine, Pediatrics, General Surgery, Eye Pathology, Eye Diseases, Implement Laser Therapy, Dry Eyes, Strabismus (Misalignment/Deviation of Eyes), Proptosis (Bulged Eyes), Excessive Tearing (Tear Duct Obstruction), Uveitis, Eye Tumors, Lacrimal Apparatus, Eye Removal, Orbital Reconstruction, Blepharoplasty, Ptosis, Ectropion, Entropion, Epicanthoplasty, Tarsorrhaphy etc.
Indexing and abstracting information
The journal is indexed with, or included in, the following:
Index Copernicus, PKP Index
The journal is registered with the following abstracting partners:
Google Scholar, Indian Science Abstracts, Academia.edu, National Science Library, J- gate, ROAD, CrossRef, Microsoft Academic.
Innovative Publication and IJOOO are committed to upholding the highest standards of ethical behaviour at all stages of publication. We strictly adhere to the industry associations such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements.
Innovative Publication has a primary partnership with CLOCKSS Archive to provide long-term digital preservation.
CLOCKSS is a collaborative project between 14 leading publishers and 34 institutional libraries to provide a ‘dark archive’ which guarantees long -term preservation and access. It uses the LOCKS technology to archive all material from participating publishers.
Ahead of Print policy
Articles published online under the “Ahead of Print” model are considered published and can be cited and quoted using DOI as the reference source. Innovative Publication has a policy that changes WILL NOT be made after the publication of an article, unless accepted procedure for making corrections to the scientific record are followed.
Open Access (OA) Publication and Creative Commons Licensing
IJOOO is an Open Access (OA) journal which uses the Gold Open Access model. Publication is funded by a fee paid at the time of acceptance, usually by an author’s institution or funder. Author(s) retain copyright of their work, with articles licensed to Innovative Publication. The vast majority of Innovative articles are distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license (https://creativecommons.org/licenses/by/4.0/) which allows others to reuse, copy and redistribute the material in any medium or format, and to alter or transform it, even commercially, as long as the author and original source are properly cited. More info.
Open Access (OA) provides a sustainable funding model for scientific communications while ensuring the widest possible access to research. Wider audiences and new readers can now freely access research articles without the hassle of payment or institutional support, that may be required to cover the expensive subscription. Open Access allows readers to use articles and data in new ways, including practices like meta-analysis and text mining, which reveal trends in science that would not be obvious at the level of individual articles.
Advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
Innovative does not endorse any product or service marked as an advertisement or promoted by a sponsor in Innovative Publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors. All advertisements and commercially sponsored publications are independent of editorial decisions. Advertisers will never be shown any manuscripts or other content prior to publication.
Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher request its removal. All advertisements for drug specific campaigns should encourage correct and rational use and must not be misleading.
Please send any complaints about advertising to: firstname.lastname@example.org
IP Innovative Publication Private Limited
Innovative Publication is a part of IP Innovative Publication Private Limited, which is one of the reputed publishers in India, with more than 125 books and 49 journals in medical, dental, nursing and pharmacy subjects in its portfolio. Our customers include professionals, institutions and students of medicine, nursing, allied health and pharmacy. Researchers, students, scholars, clinicians and other healthcare professionals access Innovative journals from around the globe to educate themselves about new and innovative discoveries and to improve patient care.
Innovative was founded in April 2011 and has become a well-respected medical publisher in India that fully supports many of the popular open access models though its peer-review management system. Innovative Open Access policy has resulted in more than five thousand articles being downloaded daily from its wide spectrum of journals.
Innovative has proven itself a leading publisher in India and has now established its global presence in more than 20 countries worldwide. From humble beginnings, it has grown into a publishing company with an annual revenue of 2.50 crore rupees in the last financial year (2018-2019).
Print and Online Scholarly Publisher, Peer-review system, Specialized in Medical, Dental, Nursing and Pharmacy books and Journals as an Open Access (OA) Publisher.